Hepatitis C Medications: Analysis of Adverse Drug Events and Poor Patient Outcomes
Calculating the costs of adverse drug reactions from post-marketing data: Implications for outcomes research
Real-world patient characteristics and survival outcomes of lenalidomide-refractory vs. lenalidomide-exposed RRMM patients in the HONEUR federated data network
